Lv4
484 积分 2024-05-28 加入
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
9天前
已完结
Iberdomide plus dexamethasone in heavily pretreated late-line relapsed or refractory multiple myeloma (CC-220-MM-001): a multicentre, multicohort, open-label, phase 1/2 trial
1个月前
已完结
Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas
1个月前
已完结
Dual Targeting of Extramedullary Myeloma with Talquetamab and Teclistamab
1个月前
已完结
Dual Targeting of Extramedullary Myeloma with Talquetamab and Teclistamab
1个月前
已完结
Dual Targeting of Extramedullary Myeloma with Talquetamab and Teclistamab
1个月前
已完结
Secondary solid cancer screening following hematopoietic cell transplantation
1个月前
已完结
[18F]FDG PET/CT for prognosis and toxicity prediction of diffuse large B-cell lymphoma patients with chimeric antigen receptor T-cell therapy
1个月前
已完结
Risk of secondary T-cell malignancy after CAR T-cell therapy
1个月前
已完结
Secondary solid cancer screening following hematopoietic cell transplantation
1个月前
已完结
皖公网安备34019202002308
